Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients

Documenti analoghi

• Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease
  di: Meijer, Esther, et al.
  Pubblicazione: (2011)
• Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
  di: Meijer, Esther, et al.
  Pubblicazione: (2010)
• Relationship of Copeptin, a Surrogate Marker for Arginine Vasopressin, With Change in Total Kidney Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results From the CRISP Cohort
  di: Boertien, Wendy E., et al.
  Pubblicazione: (2012)
• Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease
  di: Messchendorp, A. Lianne, et al.
  Pubblicazione: (2018)
• Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
  di: Messchendorp, A Lianne, et al.
  Pubblicazione: (2019)